Aldosterone and Vascular Inflammation

This publication has 86 references indexed in Scilit:

• Plasma sodium stiffens vascular endothelium and reduces nitric oxide release
  Proceedings of the National Academy of Sciences, 2007
• Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
  The Journal of Experimental Medicine, 2007
• Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
  Nature Medicine, 2007
• Pharmacological Inhibition and Genetic Deficiency of Plasminogen Activator Inhibitor-1 Attenuates Angiotensin II/Salt-Induced Aortic Remodeling
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Overexpression of Urokinase by Macrophages or Deficiency of Plasminogen Activator Inhibitor Type 1 Causes Cardiac Fibrosis in Mice
  Circulation Research, 2004
• Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ N ^G -Nitro- l -Arginine Methyl Ester-Induced Myocardial Injury
  Circulation, 2003
• Endothelin-1 Increases Vascular Superoxide via Endothelin _A –NADPH Oxidase Pathway in Low-Renin Hypertension
  Circulation, 2003
• Inflammation in atherosclerosis
  Nature, 2002
• Rapid Nongenomic Effects of Aldosterone in Mineralocorticoid-Receptor-Knockout Mice
  Biochemical and Biophysical Research Communications, 1999
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999